Moyamoya syndrome in a Malaysian child with Down syndrome

S. Vimalesvaran,N. Nachiappan,Yogeswery Sithamparanathan

DOI: https://doi.org/10.1111/jpc.12239

2013-10-01

Journal of Paediatrics and Child Health

Abstract:Moyamoya disease (MMD) is described as a chronic occlusive cerebrovascular disease characterised by progressive stenoses of the intracranial vessels. Initially, the occlusion begins at the intracranial portion of the internal carotid arteries (ICAs) but eventually extends to their branches to involve the anterior, middle and posterior cerebral arteries. There is concurrent development of an abnormal collateral vascular network, as a result of the compensatory dilatation of the lenticulostriate and thalamostriate arteries. These changes result in a typical angiographic appearance described by the Japanese as ‘something hazy, such as a puff of cigarette smoke drifting in the air’, also known as Moyamoya. While there has been a comparatively high incidence of the disease in Japan, this disease also has prevalence in Western countries. The diagnosis of Moyamoya can be readily confirmed through radiographic studies and early diagnosis is pertinent, especially in children, to prevent the increasing risk of permanent disability from strokes. The following angiographic criteria must be fulfilled for the diagnosis of MMD to be made: ‘stenosis or occlusion in the terminal portion of the ICA and in the proximal portions of the anterior cerebral artery (ACA) and the middle cerebral artery (MCA); an abnormal vascular network in the vicinity of arterial occlusion and indications of bilateral involvement’. There are two forms of the disease; primary and secondary forms. The primary form of MMD is characterised by an idiopathic finding of bilateral stenoses of the arteries of the circle of Willis with collateral vascular networks, supported by angiographic findings. The secondary form is known as Moyamoya syndrome (MMS) and has been recognised in numerous different systemic conditions such as neurofibromatosis, postradiation therapy, sickle cell disease, homocysteinuria, Graves’ disease and Down syndrome (DS). In recent years, a close association between MMS and DS has been described. This paper discusses a case of MMS in a 7-yearold child with DS. We also further review and discuss current literature regarding the association of MMS and DS.